Wall Street expects a year-over-year increase in earnings on lower revenues when Arcus Biosciences, Inc. (RCUS) reports ...

Sagimet Biosciences Inc. (NASDAQ:SGMT) surged 30% on Monday after unveiling plans to launch a Phase 3 clinical trial of ...

In September 2025, the Company launched AboutNAD®, a next-generation digital platform designed to serve as the leading online resource for scientific advancements in NAD+ research and healthy aging.

TheFly reported on April 14 that Wedbush Securities increased its price target on IDYA from $52 to $58 while maintaining an ...

Research published in The Journal of Clinical Psychiatry characterizes patient-reported improvement with INGREZZA® (valbenazine) capsules across the KINECT® clinical ...

On April 9, Niagen Bioscience Inc. (NASDAQ:NAGE) announced that Nicotinamide Riboside Chloride, the patented form of ...

“Niagen IV is now offered at over 900 clinics nationwide, including the new iCRYO locations,” stated Rob Fried, CEO of Niagen Bioscience. “This milestone highlights the growing recognition of Niagen ...

View Artelo Biosciences Inc ARTL stock quote prices, financial information, real-time forecasts, and company news from CNN.

Harvard Bioscience, a life science equipment manufacturer based in Holliston, reported a net loss of $410,000 for the company’s second quarter financials in an earnings report released on Thursday.

Harvard Bioscience, Inc. has announced that John Duke, a current Board member, will succeed Jim Green as President and CEO effective July 28, 2025, as Green prepares to retire after over eight years ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation™ (nsPFA™) energy, today announced that its nPulse™ Cardiac Catheter will be ...